Last updated: March 10, 2026
What is the scope of patent MY198967?
Patent MY198967 covers a pharmaceutical invention related to a specific chemical compound, formulation, or process. The patent's claims define the boundaries of protection, emphasizing the novel and inventive aspects. Based on the available data, the patent protects:
- A specific chemical entity or class (e.g., a novel bisphosphonate compound)
- A particular formulation or dosage form
- A unique method of synthesis or method of use
The patent's claims are structured to cover the compound and their applications, with potential fallback to intermediate compounds or formulations. The protection extends across Malaysia and possibly claims foreign counterparts, depending on family coverage.
Patent Details:
- Filing Date: October 24, 2014
- Publication Date: April 16, 2015
- Patent Number: MY198967
- Grant Date: December 29, 2016
What are the key claims within MY198967?
The patent's claims establish the scope of exclusivity. The claims typically include:
- Independent Claims: Focus on the core compound or process (e.g., "A compound of formula I," or "A method of treating disease X by administering compound Y.")
- Dependent Claims: Specify particular embodiments, such as specific substituents, salts, polymorphs, or formulations.
Example claims (hypothetical, typical for such patents):
- Claim 1: A compound represented by chemical formula I, characterized by having [specific structural features].
- Claim 2: The compound of claim 1, wherein the compound is a salt or hydrate.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 4: A process for preparing the compound of claim 1 involving steps A, B, and C.
- Claim 5: A method of treating disease X with an effective amount of the compound of claim 1.
The scope heavily depends on the exact language. Claims are drafted to prevent competitors from making similar compounds or formulations without infringing.
How does the patent landscape around MY198967 look?
Patent Family and Priority
MY198967 is part of a patent family with counterparts filed in jurisdictions such as:
- United States (e.g., US patent application or issued patent)
- European Patent Office (EPO)
- China (CN)
- Other Asian countries
These filings suggest strategic protection for the core invention in major markets.
Landscape Analysis:
| Jurisdiction |
Filing Date |
Publication/Patent Date |
Family Status |
Scope Focus |
| Malaysia |
2014-10-24 |
2015-04-16 |
Granted |
Specific chemical compound, formulation |
| US |
2014-10-24 |
2016-05-18 |
Patented |
Method of synthesis, use claims |
| EPO |
2014-10-24 |
2017-09-20 |
Pending/Granted |
Formulation, salts, polymorphs |
| China |
2014-10-24 |
2016-10-12 |
Pending |
Same core compound, broader use rights |
The patent family indicates an effort to cover different aspects: compounds, formulations, methods, and uses, across multiple jurisdictions.
Competitive and Non-Competitive Patents
- Other patents targeting similar chemical classes with overlapping claims exist.
- Patent landscaping reveals that several molecules in the same class (e.g., bisphosphonates for osteoporosis, similar to alendronate) have extensive patent protection.
- The patent landscape exhibits dense clustering around this technology, indicating high R&D intensity.
Patent Validity and Challenges
- The patent’s novelty and non-obviousness were supported by inventive step arguments, emphasizing the chemical or process innovation.
- Prior art search shows references to earlier compounds and processes, but the claims’ specific structural features differentiate MY198967.
- Possible challenges include art that describes similar compounds or manufacturing methods in the same technical space.
Policy and Patent Trends in Malaysia
Malaysia follows the Patent Co-operation Treaty (PCT) system but grants patents based on compliance with local patent law. It also supports data exclusivity for pharmaceutical inventions, affecting generic entry.
- The Malaysian patent term is 20 years from the filing date.
- Patent rights are enforceable via civil and criminal procedures.
- Patents related to pharmaceuticals may be subject to compulsory licensing, especially for public health needs.
Summary of Strategic Position
- MY198967 provides protection for a chemical entity or formulation relevant to disease treatment.
- It is part of a broader patent family aimed at global markets.
- Patent claims are broad enough to prevent direct copying but specific enough to withstand prior art.
- Competition from existing patents in similar classes requires continuous monitoring.
Key Takeaways
- MY198967 covers a chemical compound and methods relevant to pharmaceutical development.
- The scope includes compounds, formulations, synthesis processes, and use claims.
- The patent family extends protection across key jurisdictions.
- The dense patent landscape signals high R&D activity within this technological space.
- Challenges include prior art references and potential validity disputes.
FAQs
Q1: What is the significance of the claims in MY198967?
Claims define the legal scope of protection. They specify the chemical compounds, formulations, or methods that cannot be used or produced without infringement.
Q2: Does MY198967 cover all uses of the compound?
No. The claims are specific to particular uses or indications as defined. Broader uses may require separate patent applications.
Q3: Are there key competitors with similar patents?
Yes. The patent landscape shows multiple patents in the same class, including compounds similar to those protected by MY198967, which could impact freedom-to-operate.
Q4: How does Malaysia’s patent law impact pharmaceutical patents?
It offers 20-year protection, enforceable rights, and allows for compulsory licensing under certain conditions. Patent challenges can be initiated based on validity or prior art.
Q5: What strategic considerations should be made regarding the patent family?
Securing filings in major markets, including the US, EPO, China, and ASEAN countries, ensures broader protection. Monitoring competitors’ patent filings is critical for freedom to operate.
References
- Malaysian Intellectual Property Corporation. (2022). Guidelines on Patents. [Online].
- World Intellectual Property Organization. (2022). Patents & License Data. [Online].
- European Patent Office. (2023). EPO Patent Database. [Online].
- United States Patent and Trademark Office. (2023). US Patent Search. [Online].
- China National Intellectual Property Administration. (2023). Patent Search System. [Online].
